Drugs / CD79b CAR-T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04609241 | Nov 2020 → Nov 2023 overdue | B-cell non-Hodgkin lymphoma, acute lymphoblastic leukemia | Zhejiang University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD79b CAR-T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04609241 ↗ |
| Modality | Cell therapy | “CD79b CAR-T Cells” NCT04609241 ↗ |
| Target | CD79B | “CD79b CAR-T Cells” NCT04609241 ↗ |